VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IWWM-11 2022 | An insight into a novel MYD88 transgenic model being used to investigate WM

Ruben Carrasco, MD, PhD, Dana-Farber Cancer Institute, Boston, MA, shares some insights into a novel MYD88 transgenic model being used to investigate mutations in Waldenström’s macroglobulinemia (WM). This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter